Phyto Chem (India) Ltd
₹ 35.7
-0.25%
12 Feb
- close price
- Market Cap ₹ 15.4 Cr.
- Current Price ₹ 35.7
- High / Low ₹ 42.9 / 26.4
- Stock P/E
- Book Value ₹ 14.0
- Dividend Yield 0.00 %
- ROCE -4.93 %
- ROE -38.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.55 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -24.2% over past five years.
- Company has a low return on equity of -9.99% over last 3 years.
- Company has high debtors of 388 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.29 | 29.29 | 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 13.08 | |
28.97 | 26.32 | 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 16.66 | |
Operating Profit | 2.32 | 2.97 | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -3.58 |
OPM % | 7.41% | 10.14% | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -27.37% |
0.51 | -0.06 | 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 4.05 | |
Interest | 1.56 | 1.63 | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.70 |
Depreciation | 0.30 | 0.35 | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.33 |
Profit before tax | 0.97 | 0.93 | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.56 |
Tax % | 34.02% | 34.41% | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | |
0.64 | 0.61 | 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -1.55 | |
EPS in Rs | 1.49 | 1.42 | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -3.61 |
Dividend Payout % | 67.19% | 70.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -7% |
5 Years: | -24% |
3 Years: | -31% |
TTM: | -32% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -3% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 11% |
3 Years: | 17% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | -5% |
3 Years: | -10% |
Last Year: | -38% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
Reserves | 3.00 | 3.12 | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 1.71 |
11.95 | 14.22 | 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 19.40 | |
7.93 | 10.53 | 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 7.84 | |
Total Liabilities | 27.18 | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 33.25 |
3.83 | 4.21 | 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.57 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.32 | 0.32 | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.08 |
23.03 | 27.64 | 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 30.60 | |
Total Assets | 27.18 | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 33.25 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-1.78 | -1.71 | -2.13 | -0.34 | 1.53 | 0.76 | 1.95 | 1.49 | -0.71 | 3.41 | 1.42 | 3.41 | |
-0.65 | -0.71 | 0.32 | 0.60 | 0.16 | 0.24 | 0.26 | -0.39 | 1.06 | 0.05 | 0.21 | -0.05 | |
2.38 | 2.43 | 1.79 | -0.48 | -1.76 | -1.02 | -2.19 | -1.10 | -0.40 | -3.45 | -1.70 | -3.26 | |
Net Cash Flow | -0.05 | 0.01 | -0.02 | -0.23 | -0.06 | -0.01 | 0.02 | -0.01 | -0.05 | 0.01 | -0.07 | 0.10 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 157.25 | 209.73 | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 |
Inventory Days | 133.97 | 167.93 | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 |
Days Payable | 76.58 | 99.24 | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 |
Cash Conversion Cycle | 214.64 | 278.42 | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 |
Working Capital Days | 174.28 | 211.60 | 173.04 | 340.19 | 192.81 | 140.42 | 165.18 | 226.08 | 213.39 | 452.62 | 377.55 | 569.40 |
ROCE % | 13.89% | 13.06% | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% |
Documents
Announcements
-
Results-Financial Results For Dec 31, 2024 (Submission Of Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations, 2015 - Reg.)
1d - Submission of unaudited financial results for Q3 2024.
-
Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI
(LODR) Regulations, 2015 -
Regarding.
2d - Board approved unaudited financial results for Q3 2024.
-
Board Meeting Intimation for Intimation Of Board Meeting To Take On Record Unaudited Financial Results For The Quarter Ended 31St December, 2024 Under Regulation 33 Of The SEBI(LODR) Regulation, 2015 - Regarding
1 Feb - Board meeting to discuss Q3 financial results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jan - Certificate under SEBI regulations for dematerialization.
-
Closure of Trading Window
31 Dec 2024 - Closure of trading window for insider trading regulations.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is in the business of manufacturing & marketing of pesticides for agriculture sector. It works in 3 segments i.e. Pesticides Formulations, Food Division and Real Estate Activities. Company has a marketing network in Telangana, Andhra Pradesh, Maharashtra and Karnataka and their products are marketed with its own brands through dealers & distributors network.
In FY22, company started marketing of Food products and is continuing Real Estate activity in a small way in Bengaluru for the last few years